Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-145

Look for all us long term holders, we must enjoy the journey this company is taking to greatness. This is not approval or accelerated approval, but with the link up with Novartis, enough Data coming through to keep the FDA happy, and the Covid crisis hitting America as winter hits, well you had Bunting well enjoy this moment. We know are product works, it is why we are holding. Momentous! I believe was the word Silvu used recently. I hate to disagree with the great man, and please don’t report this comment, but I believe he may have understated the situation. This will play out over the next several weeks, let’s enjoy the green. Cato don’t leave us too soon, however expect a big spike and then some profit taking today. I’m holding for the long term.